DNA damage and apoptosis in the aged canine brain: Relationship to Aβ deposition in the absence of neuritic pathology

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 24, Issue 5, 2000, Pages 787-799

  Anderson, Aileen J ^a   Ruehl, William W ^b   Fleischmann, Lisa K ^b   Stenstrom, Kristol ^b   Entriken, Theresa L ^b   Cummings, Brian J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Deprenyl Animal Health Inc   (United States)

Author keywords

Alzheimer disease; Amyloid; A ; Canine; DNA damage; TUNEL

Indexed keywords

AMYLOID BETA PROTEIN;

AGING; ALZHEIMER DISEASE; ANIMAL MODEL; APOPTOSIS; BRAIN DISEASE; DNA DAMAGE; DNA DETERMINATION; DOG; DOWN SYNDROME; NEURITE; NEUROPATHOLOGY; NICK END LABELING; NONHUMAN; REVIEW;

EID: 0033874893     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(00)00106-8     Document Type: Article

References (43)

1. Evidence for DNA damage and apoptosis in Down syndrome and Alzheimer disease
2. DNA damage and apoptosis in Alzheimer's disease: Colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay
3. β-amyloid accumulation correlates with cognitive dysfunction in the aged canine
4. The canine as an animal model of human aging and dementia
5. 40: Evidence from cats and dogs
6. Image analysis of beta-amyloid load in Alzheimer's disease and relation to dementia severity
7. β-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease
8. β-amyloid accumulation in aged canine brain: A model of early plaque formation in Alzheimer's disease
9. Aggregation of the amyloid precursor protein (APP) within degenerating neurons and dystrophic neurites in Alzheimer's Disease
10. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes
11. Increased nuclear DNA oxidation in the brain of Alzheimer disease
12. Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity
13. Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides
14. Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease
15. Visual-discrimination learning ability and beta-amyloid accumulation in the dog
16. Predicting the presence and location of amyloid deposition in a canine model of human aging and dementia using logistic regression analyses
17. Expression of DNA excision-repair and cross-complementing proteins p80 and p89 in brains of patients with Down syndrome and Alzheimer disease
18. β-amyloid induced local neurite degeneration in cultured hippocampal neurons: Evidence for neuritic apoptosis
19. Programmed cell death (apoptosis) in Alzheimer's disease and Creutzfeldt-Jakob disease
20. Apoptosis in the aged dog brain
21. Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32 in Alzhiemer's disease
22. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ
23. Intracellular accumulation of detergent-soluble amyloidogenic A beta fragment of Alzheimer's disease precursor protein in the hippocampus of aged transgenic mice
24. Terminal dUTP nick-end labeling (TUNEL) positive cells in the difference regions of the brain in normal aging and Alzheimer patients
25. Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF
26. DNA damage distribution in the human brain as shown by in situ end labeling; Area-specific differences in aging and Alzheimer disease in the absence of apoptotic morphology
27. An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer disease
28. Accumulation of DNA damage in aging neurons occurs through a mechanism other than apoptosis
29. Neurons in the cerebral cortex are most susceptible to DNA-damage in aging rat brain
30. Lipoprotein-free amyloidogenic peptides in plasma are elevated in patients with sporadic Alzheimer's disease and Down's syndrome
31. Increased expressio of the TIAR protein in the hippocampus of Alzheimer patients
32. A suicide note from Alzheimer disease neurons?
33. Evidence for apoptotic cell death in Hunthinton disease and excitotoxic animal models
34. Immunoreactivity for Bcl-2 protein within neurons in the Alzheimer's disease brain increases with disease severity
35. Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease
36. Progressive neuronal DNA damage associated with neurofibrillary tangle formation in Alzheimer disease
37. Immunohistochemical evidence for DNA fragmentation in neurons in the AD brain
38. Upregulation of Bcl-2 is associated with neuronal DNA damage in Alzheimer's disease
39. Magnetic resonance imaging of anatomic and vascular characteristics in a canine model of human aging
40. Topographic associations between DNA fragmentation and Alzheimer's disease neuropathology in the hippocampus
41. In situ labeling of dying cortical neurons in normal aging and in Alzheimer's disease: Correlations with senile plaques and disease progression
42. Senile plaques and cerebral amyloidosis in aged dogs: A histochemical and ultrastructural study
43. Intracellular A beta 1-42 aggregates stimulate the accumulation of stable, insoluble amyloidogenic fragments of the amyloid precursor protein in transfected cells